Status:
UNKNOWN
"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Coronary Angiography
Eligibility:
All Genders
18-80 years
Phase:
EARLY_PHASE1
Brief Summary
The investigators will investigate patients undergoing coronary angiography with normal coronary but slow blood flow that was normalized after adenosine injection into the coronary artery. The investi...
Eligibility Criteria
Inclusion
- Patients undergoing coronary angiography and who have normal coronary artery with slow blood flow that normalized with adenosine injection into the coronary artery
Exclusion
- Significant coronary disease
- Unstable patients
- Patients with known sensitivity to dipyridamole
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00960817
Last Update
August 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100